GENE ONLINE|News &
Opinion
Blog

2021-10-21| Asia-Pacific

The 8 Companies Propelling Taiwan’s Biopharma Industry

by Joy Lin
Share To
In the world of biotech and pharma, the promise of high returns comes hand in hand with high risks, but that’s hardly surprising. Most companies have to equip themselves with the know-how and technology to get a foothold in the international market.

At the same time, they must grapple with high development costs and lengthy trials. When one considers Taiwan's limited resources, few companies stand out, but those do bear outstanding resumes with the potential to challenge international competitors. 

From the pool of biotechs and pharmas in Taiwan, we handpick 8 noteworthy companies based on their clinical progress and overseas achievements. Among them, some have even made big breakthroughs in treatments for cancer, AIDS, and Alzheimer's disease.

Others have a polished track record as a vaccine developer or an international contract development and manufacturing organization (CDMO). Through this article, you will be able to quickly understand what's trending in Taiwan's biotech scene.

GO Prime with only $1.49 now

LATEST
Freenome Raises $300 Million Series D for Cancer-Detecting Multiomics Platform
2021-12-08
Novel RAGE Antagonist Stirs Hopes for Countering Diabetic Complications
2021-12-07
AstraZeneca Blocks Private Equity Buyout of Swedish Pharma Sobi
2021-12-06
Coherent Biopharma, WuXi STA Collab Takes a Crack at Peptide-Drug Conjugates
2021-12-06
How CDMOs are Restructuring the Biopharma Landscape – An Interview with Bobby Sheng
2021-12-06
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Novartis, UCB Take Aim at Parkinson’s Disease Under $1.65 Billion Collab
2021-12-03
EVENT
2021-12-13
63rd ASH ANNUAL MEETING AND EXPOSITION
Georgia, USA
2021-12-28
BIOHK2021
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!